NYU Langone's Perlmutter Cancer Center
Latest from NYU Langone's Perlmutter Cancer Center
Adagrasib Demonstrates CNS Activity in KRAS G12C+ NSCLC
June 21, 2022
Article
The intracranial objective response rate was 32% among patients with KRAS G12C–mutant, non–small cell lung cancer who received adagrasib.
Checkpoint Blockade Drives Progress in Endometrial Cancer Treatment
November 13, 2021
Article
An expert from NYU Langone outlines how checkpoint blockade approvals have helped advance endometrial cancer management.
Oncology Nurse Champion: Kathleen Lutz
August 02, 2021
Article
From orchestrating local infusion appointments to making lunch for a patient, Kathleen Lutz, RN, NP-BC WH, constantly strives to provide an excellent level of supportive care.